Published in Bull World Health Organ on January 01, 1987
TROPHOBLASTIC TUMORS; GEOGRAPHICAL VARIATIONS IN INCIDENCE AND POSSIBLE AETIOLOGICAL FACTORS. J Obstet Gynaecol Br Commonw (1965) 1.38
THE POSSIBLE ETIOLOGIC FACTORS OF HYDATIDIFORM MOLE AND CHORIOCARCINOMA: PRELIMINARY REPORT. Am J Obstet Gynecol (1965) 1.11
Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965. Acta Obstet Gynecol Scand (1970) 1.01
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med (1998) 9.03
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology (1987) 3.65
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology (2001) 2.72
Variants of the adenomatoid odontogenic tumor with a note on tumor origin. J Oral Pathol Med (1992) 1.84
Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer (1988) 1.83
Clear cell carcinoma of liver. An ultrastructural study. Cancer (1983) 1.72
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology (1997) 1.62
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology (1992) 1.44
Histologic prognostic indicators in hepatocellular carcinoma. Cancer (1979) 1.43
Synergism of chronic alcoholism and hepatitis B infection in liver disease. J Gastroenterol Hepatol (1991) 1.40
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology (1988) 1.28
Inflammatory pseudotumour of the mouth and maxilla. J Clin Pathol (1996) 1.28
Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology (2000) 1.27
Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol (1987) 1.24
Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet (1987) 1.20
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea. Lancet (1983) 1.20
Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer (1981) 1.19
In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm (2001) 1.19
Cell division of Escherichia coli: control by membrane organization. J Bacteriol (1973) 1.18
Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol (1993) 1.16
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer (2001) 1.16
Desmoplastic variant of ameloblastoma in Chinese patients. Br J Oral Maxillofac Surg (1998) 1.15
Osteochondroma of the coronoid process of the mandible. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol (1993) 1.12
Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol (1991) 1.12
An autopsy study of hepatocellular carcinoma in Hong Kong. Pathology (1981) 1.09
Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med (1989) 1.09
Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet (1988) 1.08
A survey of tumours of the jawbones in Hong Kong Chinese: 1963-1982. Br J Oral Maxillofac Surg (1985) 1.06
Exposure assessment of indoor allergens, endotoxin, and airborne fungi for homes in southern Taiwan. Environ Res (2001) 1.04
Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol (1992) 1.01
Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology (1993) 0.99
Ameloblastic carcinoma of the jaws. A report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.96
Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial. Br J Cancer (1989) 0.95
A case of invasive penicilliosis in Hong Kong with immunologic evaluation. Am Rev Respir Dis (1985) 0.95
Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J Hepatol (1999) 0.95
Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculature. Surgery (1999) 0.94
Cytoplasmic hepatitis B surface antigen and the ground-glass appearance in hepatocellular carcinoma. Am J Clin Pathol (1979) 0.94
Serum alpha-fetoprotein in rats after ligation of the common bile duct: relation to ductular cell (oval cell) proliferation. J Pathol (1981) 0.94
Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med (1991) 0.92
Interferon therapy of chronic hepatitis B virus infection in Chinese. J Hepatol (1986) 0.92
Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS (1995) 0.92
Raised serum hCG in a male patient caused by primary jejunal choriocarcinoma. J Clin Pathol (1998) 0.91
Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Cancer (1987) 0.89
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis. J Clin Pharmacol (1999) 0.89
Fungal exposure of children at homes and schools: a health perspective. Arch Environ Health (2001) 0.89
Wilson's disease: 35 years' experience. Q J Med (1990) 0.88
An oligonucleotide probe for the detection of hepatitis B virus DNA in serum. J Virol Methods (1987) 0.88
Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology (1998) 0.87
Treatment of chronic hepatitis B with interferon: experience in Asian patients. Semin Liver Dis (1989) 0.87
Renal metastases of choriocarcinoma. A clinicopathological study of 31 cases. Chin Med J (Engl) (1991) 0.86
Apoptosis and viral hepatitis. Semin Liver Dis (1998) 0.86
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II). Cytokine (2000) 0.86
Detection of hepatitis C virus genome in formalin-fixed paraffin-embedded liver tissue by in situ reverse transcription polymerase chain reaction. J Med Virol (1994) 0.86
Mesenchymal hamartoma of liver in a man: comparison with cases in infants. J Clin Pathol (1994) 0.86
The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS (1997) 0.85
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut (1985) 0.85
Phosphonoformic acid-inhibitable nucleotide incorporation as a measure of hepatitis B viral DNA polymerase activity. J Med Virol (1983) 0.85
Schottky junction photovoltaic devices based on CdS single nanobelts. Nanotechnology (2009) 0.84
Massive maxillary ameloblastic fibro-odontoma: case report with surgical management. J Oral Maxillofac Surg (1990) 0.84
Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med (1984) 0.84
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. Cancer Res (1999) 0.84
Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model. Int J Immunopathol Pharmacol (2012) 0.83
Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr (1994) 0.83
Variations of hepatitis B virus core gene sequence in Western patients with chronic hepatitis B virus infection. J Viral Hepat (1997) 0.83
Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci (1992) 0.82
Case report of symptomatic porphyria cutanea tarda associated with histiocytic lymphoma. Cancer (1984) 0.82
Cementoblastoma in Hong Kong Chinese. A report of four cases. Oral Surg Oral Med Oral Pathol (1992) 0.82
A staging system of gestational trophoblastic neoplasms based on the development of the disease. Chin Med J (Engl) (1984) 0.82
Adhesion and colonisation of Candida krusei on host surfaces. J Med Microbiol (1994) 0.81
[Interventional therapy of hepatic cavernous hemangioma]. Zhonghua Wai Ke Za Zhi (1994) 0.81
Ribonucleotide vanadyl complexes inhibit polymerase chain reaction. Nucleic Acids Res (1993) 0.81
Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976. Br J Cancer (1980) 0.81
Resection of pulmonary metastatic choriocarcinoma in 43 drug-resistant patients. Ann Thorac Surg (1985) 0.81
Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. Am J Obstet Gynecol (1988) 0.81
Etiological spectrum of liver cirrhosis in the Chinese. J Chronic Dis (1980) 0.81
The carriage of Escherichia coli resistant to antibiotics in healthy populations in Shanghai. Biomed Environ Sci (1998) 0.81
Interferon treatment for hepatitis C virus infection in patients on haemodialysis. Nephrol Dial Transplant (1997) 0.80
Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions. Histopathology (1989) 0.80
Single-dot spectroscopy via elastic single-electron tunneling through a pair of coupled quantum dots. Phys Rev Lett (2004) 0.80
Hepatitis B surface antigen in hepatocytes at necropsy. Arch Pathol Lab Med (1980) 0.80
Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar. J Natl Cancer Inst (1982) 0.80
The ether lipid tumour marker in human liver with hepatocellular carcinoma. Br J Cancer (1980) 0.80
Subclinical hepatocellular carcinoma in Hong Kong Chinese. Oncology (1992) 0.80
The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa. J Med Microbiol (1998) 0.80
Prednisolone in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study. Hepatology (1983) 0.80
Induction of cell proliferation arrest and apoptosis in hepatoma cells through adenoviral-mediated transfer of p53 gene. J Hepatol (2000) 0.80
Micromethod for phosphonoformate inhibition assay of hepatitis B viral DNA polymerase. Clin Chem (1984) 0.79
Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol (1986) 0.79
Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation. J Clin Pathol (1997) 0.79
Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int J Cancer (1981) 0.79
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. J Hepatol (1998) 0.79
Molecular hybridization study of plasma hepatitis B virus DNA from different carriers. J Infect Dis (1986) 0.79
Keratoma hereditaria mutilans: report of a case with successful surgical treatment. J Hand Surg Am (1986) 0.79
Chondrosarcoma of the mandible presenting as periodontal lesions: report of 2 cases. J Craniomaxillofac Surg (1994) 0.79
Operon coordination in different bacterial hosts. J Bacteriol (1970) 0.79
Alpha-interferon treatment in Chinese patients with chronic hepatitis B. J Hepatol (1990) 0.78
Kinetics and hydrolysis mechanism of polymeric prodrugs containing ibuprofen, ketoprofen, and naproxen as pendent agents. J Biomater Sci Polym Ed (2002) 0.78
A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection. J Med Virol (1991) 0.78
Transdermal delivery of sodium nonivamide propionate by iontophoresis. Biol Pharm Bull (1998) 0.78